Cover image of the article: Paraclinical disorders and prevalence of viral infections in injection drug users

Image Credit:J Inflamm Dis

Paraclinical disorders and prevalence of viral infections in injection drug users

Authors

F Khorvash,*, M Fasihi Dastjerdi, AR Emami Naeini
*Corresponding Author: Email: fkhorvash@mail.com

Journal of Inflammatory Diseases:Vol. 13, issue 2; 23-29
Published online:Sep 30, 2009
Article type:Research Article
How to Cite:Khorvash F, Fasihi Dastjerdi M, Emami Naeini A. Paraclinical disorders and prevalence of viral infections in injection drug users. J Inflamm Dis. 2024;13(2):e155465. doi:

Abstract

Background: It is reported that 24-40 % of hospital admissions in the world are related to addiction and its complications. Considering hepatitis, AIDS, cirrhosis and various malignancies following these complications, addiction is one of the most important problems in treatment centers worldwide. Objective: To determine Para clinical disorders and prevalence of viral infections in injection drug users Methods: This was a cross-sectional study in which Para clinical derangements including lab results, chest radiography, and abdominal and pelvic sonography of all patients admitted to infectious diseases ward at Al-Zahra hospital in Isfahan were evaluated during 2005. Also, the presence of HIV, HCV, and HBV infections in these patients during two consecutive years of 2004 and 2005 was taken into consideration. Findings: The total number of patients during 2 years was 92 among those 53 hospitalized during 2005 and 39 in 2004. The mean age was 31.7 years with an age range between 20 and 53. The mean length of injection was 3.9 years with a minimum of 2 months and a maximum of 21 years. Among patients hospitalized in 2005, 47% were abnormal for chest radiographs and 17% found to have splenomegaly based on sonography. Among these patients, leucocytosis (85.5%), anemia 86%), higher levels of ESR (74%), derangement in liver tests (60%) and coagulation disorders (55%) were also observed. Viral infections in patients admitted during 2004 were HCV (71%), HBV (12.8%), and HIV (7.6%) while 25.6% were negative for viral infection. In patients hospitalized through 2005, the viral infections were due to HCV (74.3%), HBV (14.3%), and HIV (17%) whereas 17% of patients found to be without viral infection. Conclusion: Based on data found in our study, the high prevalence of viral infection and Para clinical disorders in these patients highlights the importance and the urgency of such laboratory measurements at the very beginning following hospitalization.

Highlights

Copyright

© 2024, Journal of Inflammatory Diseases. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.

Similar Articles

30
Jun
2010
Seroprevalence Study of Hepatitis C and Hepatitis B Virus among Hospitalized Intravenous Drug Users in Ahvaz, Iran (2002-2006)

Seroprevalence Study of Hepatitis C and Hepatitis B Virus among Hospitalized Intravenous Drug Users in Ahvaz, Iran (2002-2006)

Seyed Mohammad Alavi,
Fatemeh Behdad

Alavi S, Behdad F. Seroprevalence Study of Hepatitis C and Hepatitis B Virus among Hospitalized Intravenous Drug Users in Ahvaz, Iran (2002-2006). Hepat Mon. 2010;10(2):. doi:

31
Jan
2008
Relative frequency of infections among hospitalized injecting drug user-HIV positive patients in Razi hospital, Ahvaz, SW Iran (2001-2003)

Relative frequency of infections among hospitalized injecting drug user-HIV positive patients in Razi hospital, Ahvaz, SW Iran (2001-2003)

Seyed Mohammad Alavi

Alavi SM. Relative frequency of infections among hospitalized injecting drug user-HIV positive patients in Razi hospital, Ahvaz, SW Iran (2001-2003). Jundishapur J Microbiol. 2008;1(1):. doi:

30
Apr
2006

Prevalence of Intravenous Drug Use Associated Infections

Sorour Asadi,
Majid Marjani

Asadi S, Marjani M. Prevalence of Intravenous Drug Use Associated Infections. Arch Clin Infect Dis. 2006;1(2):. doi:

31
Mar
2008
Prevalence and Risk Factors of Hepatitis B Infection in Injection Drug Users, Tehran (2001-2002)

Prevalence and Risk Factors of Hepatitis B Infection in Injection Drug Users, Tehran (2001-2002)

Hamid Tavakkoli,
Mohammad Mahdi Mir-Nasseri,
Hossein Poustchi,
Parviz Afshar,
Mohammad Nabi Motalebi,
Ashraf Mohammadkhani
,et al.

Tavakkoli H, Mir-Nasseri M, Poustchi H, Afshar P, Motalebi M, et al. Prevalence and Risk Factors of Hepatitis B Infection in Injection Drug Users, Tehran (2001-2002). Hepat Mon. 2008;8(1):. doi:

31
Dec
2011
Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran

Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran

Masoumeh Amin-Esmaeili,
Masoumeh Amin-Esmaeili,
Afarin Rahimi-Movaghar,
Afarin Rahimi-Movaghar,
Emran M. Razaghi,
Emran M. Razaghi
,et al.

Amin-Esmaeili M, Amin-Esmaeili M, Rahimi-Movaghar A, Rahimi-Movaghar A, Razaghi E, et al. Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran. Hepat Mon. 2011;12(1):. doi: https://doi.org/10.5812/kowsar.1735143X.806

More by these authors

F KhorvashPubMedScholar
M Fasihi DastjerdiPubMedScholar
AR Emami NaeiniPubMedScholar
Share
Cited by
Metrics